The potential translational significance of these findings is that GSK3i may allow the stimulation of KITLG expression e.g. in patients with ICC loss without concomitant activation of the pathways that mediate IGF1’s actions promoting cellular stress, aging and cancer [14,15]. The gene discussed is IGF1; the disease is intrahepatic cholangiocarcinoma.